Bravaccini, S., & Ulivi, P. (2020). What’s the best modality for patient selection for predicting response to PD-1/PD-L1 inhibitors? Transl Lung Cancer Res.
Čikaški stil citiranjaBravaccini, Sara, i Paola Ulivi. "What’s the Best Modality for Patient Selection for Predicting Response to PD-1/PD-L1 Inhibitors?" Transl Lung Cancer Res 2020.
MLA način citiranjaBravaccini, Sara, i Paola Ulivi. "What’s the Best Modality for Patient Selection for Predicting Response to PD-1/PD-L1 Inhibitors?" Transl Lung Cancer Res 2020.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.